7,978 Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Acquired by Atria Investments Inc
Atria Investments Inc bought a new position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) in the 4th quarter, HoldingsChannel.com reports. The fund bought 7,978 shares of the specialty pharmaceutical company’s stock, valued at approximately $288,000. A number of other institutional investors and hedge funds have also bought and sold shares of SUPN. Smartleaf Asset […]
Atria Investments Inc bought a new position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) in the 4th quarter, HoldingsChannel.com reports. The fund bought 7,978 shares of the specialty pharmaceutical company’s stock, valued at approximately $288,000. A number of other institutional investors and hedge funds have also bought and sold shares of SUPN. Smartleaf Asset […]
